Goodwin Advised Aclarion on the $4.7 Million Closing of Registered Direct Offering of Common Stock
February 04, 2025
February 04, 2025
BOSTON, Massachusetts, Feb. 4 -- Goodwin, a law firm, issued the following news release:
The Life Sciences team advised Aclarion (Nasdaq: ACON, ACONW) on the closing of its registered direct offering of 506,803 shares of its common stock at a price per share of $9.25. All of the shares in the offering were sold by Aclarion. The gross proceeds to Aclarion from this offering were approximately $4.7 million, before deducting the placement agent's fees and other offering expenses p . . .
The Life Sciences team advised Aclarion (Nasdaq: ACON, ACONW) on the closing of its registered direct offering of 506,803 shares of its common stock at a price per share of $9.25. All of the shares in the offering were sold by Aclarion. The gross proceeds to Aclarion from this offering were approximately $4.7 million, before deducting the placement agent's fees and other offering expenses p . . .